CMS Issues Interim Final Rule Establishing New COVID Treatment Add-On Payment

By
Original story posted on: December 21, 2020

Comments are being sought now.

With two COVID-19 vaccines now being distributed nationwide and more on the way, in addition to what are sure to be forthcoming enhancements in treatment of the virus, federal officials have issued an interim final rule with comment period establishing add-on payments for such measures.  

The Centers for Medicare & Medicaid Services (CMS) issued an MLN Connects Special Edition post about the New COVID-19 Treatments Add-on Payment (NCTAP) under the Inpatient Prospective Payment System (IPPS) on Monday, noting that the payments will remain in effect retroactively from Nov. 2, 2020 through the termination of the federally declared COVID public health emergency (PHE).

“To mitigate potential financial disincentives for hospitals to provide new COVID-19 treatments during the COVID-19 PHE, the Medicare program will provide an enhanced payment for eligible inpatient cases that involve use of certain new products with current Food and Drug Administration approval or emergency use authorization to treat COVID-19,” the post read.

According to the CMS document published in the Federal Register memorializing the interim rule, the move specifically centers on the agency’s interpretation of Section 3713 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which established Part B coverage and payments for the COVID vaccine and its administration.

To review the Federal Register post in its entirety, including steps on how to comment and a contact for more information, go online to https://www.federalregister.gov/documents/2020/11/06/2020-24332/additional-policy-and-regulatory-revisions-in-response-to-the-covid-19-public-health-emergency.

For more information about the new add-on payments generally, go to the CMS NCTAP web page at https://www.cms.gov/medicare/covid-19/covid-19-treatments-add-payment-nctap.

The global COVID pandemic has now reportedly sickened more than 77 million worldwide, killing 1.7 million, and daily global cases and deaths are currently hovering at or near all-time highs, both domestically and internationally. The U.S. has recorded more than 18 million cases and nearly 325,000 deaths.

Mark Spivey

Mark Spivey is a national correspondent for ICDmonitor.com who has been writing on numerous topics facing the nation’s healthcare system (and federal oversight of it) for five years.

Related Stories

  • COVID-19 Vaccination: Not fast enough
    The vaccination effort has been suboptimal. It is mind-boggling how rapidly they were able to develop effective vaccines against COVID-19. It really was at warp speed. However, vaccines don’t protect people, vaccinations do. The vaccination effort has been suboptimal. In…
  • The COVID Healthcare Professional Grind
    Burnout in healthcare professionals, physicians in particular, was high pre-COVID. We are hearing stories every day about healthcare delivery professionals being caught up in the stress of the intense, long hours necessary to deliver care to COVID-19 patients. There have…
  • COVID-19 Relief Bill Adds Surprises to 2021 Final Rule, MPFS
    The conversion factor was increased twice in one week. The Centers for Medicare & Medicaid Services  (CMS), in a rare move, recently raised the  conversion factor (CF) twice in one week, resulting in an adjustment of approximately $34.89 for 2021.…